These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23117888)

  • 1. Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension.
    Saito Y; Nakamura K; Miyaji K; Akagi S; Mizoguchi H; Ogawa A; Fuke S; Fujio H; Kiyooka T; Nagase S; Kohno K; Morita H; Kusano KF; Matsubara H; Ohe T; Ito H
    J Pharmacol Sci; 2012; 120(3):206-12. PubMed ID: 23117888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the optimum dose for the intravenous administration of nicardipine in the treatment of acute heart failure--a multicenter study. The Nicardipine Heart Failure Study Group.
    Hirota Y; Kawai C; Hori R; Okumura K; Kinoshita M; Kumada T; Ogawa H; Kawamura K; Kusukawa R
    Jpn Circ J; 1997 May; 61(5):367-74. PubMed ID: 9192235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Gerhardt F; Fiessler E; Olsson KM; Kayser MZ; Kovacs G; Gall H; Ghofrani HA; Badr Eslam R; Lang IM; Benjamin N; Grünig E; Halank M; Lange TJ; Ulrich S; Leuchte H; Held M; Klose H; Ewert R; Wilkens H; Pizarro C; Skowasch D; Wissmüller M; Hellmich M; Olschewski H; Hoeper MM; Rosenkranz S
    Circulation; 2024 May; 149(20):1549-1564. PubMed ID: 38606558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Vascular Capacitance is Associated with Vasoreactivity and Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension.
    Cheng XL; He JG; Liu ZH; Gu Q; Ni XH; Zhao ZH; Luo Q; Xiong CM
    Lung; 2016 Aug; 194(4):613-8. PubMed ID: 27272652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
    Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Vasodilator Testing in Pulmonary Hypertension.
    Sharma A; Obiagwu C; Mezue K; Garg A; Mukherjee D; Haythe J; Shetty V; Einstein AJ
    Prog Cardiovasc Dis; 2016; 58(4):425-33. PubMed ID: 26434988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
    Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM;
    J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.
    Tonelli AR; Alnuaimat H; Mubarak K
    Respir Med; 2010 Apr; 104(4):481-96. PubMed ID: 20004088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
    Hecht JP; Richards PG
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
    Halliday SJ; Hemnes AR; Robbins IM; Pugh ME; Zhao DX; Piana RN; Fong PP; Brittain EL
    J Heart Lung Transplant; 2015 Mar; 34(3):312-8. PubMed ID: 25577565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers.
    Zuo XR; Zhang R; Jiang X; Li XL; Zong F; Xie WP; Wang H; Jing ZC
    Am J Cardiol; 2012 Jun; 109(12):1801-6. PubMed ID: 22459309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
    Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
    Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.
    Sitbon O; Humbert M; Jagot JL; Taravella O; Fartoukh M; Parent F; Herve P; Simonneau G
    Eur Respir J; 1998 Aug; 12(2):265-70. PubMed ID: 9727772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of hypotension induced by KRN2391 and nicardipine in isoflurane anaesthetized dogs.
    Takeda S; Ozawa Y; Tomaru T
    Can J Anaesth; 1997 Sep; 44(9):1002-7. PubMed ID: 9305565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antihypertensive effects of nicardipine with nitroglycerin for perioperative hypertension.
    Chen TL; Sun WZ; Cheng YJ; Lee TS; Lin SY; Lin CJ
    Acta Anaesthesiol Sin; 1995 Dec; 33(4):199-204. PubMed ID: 8705151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicardipine to control mean arterial pressure during extracorporeal membrane oxygenation.
    Tobias JD; Pietsch JB; Lynch A
    Paediatr Anaesth; 1996; 6(1):57-60. PubMed ID: 8839090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment.
    Hirakawa K; Asano R; Ueda J; Aoki T; Tsuji A; Ogo T
    Int J Cardiol; 2024 Jul; 406():132043. PubMed ID: 38614366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today?
    Medarov BI; Judson MA
    Respir Med; 2015 May; 109(5):557-64. PubMed ID: 25666253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.